Rockwell Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RMTI and other ETFs, options, and stocks.

About RMTI

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. 

CEO
Mark Strobeck
CEOMark Strobeck
Employees
244
Employees244
Headquarters
Wixom, Michigan
HeadquartersWixom, Michigan
Founded
1996
Founded1996
Employees
244
Employees244

RMTI Key Statistics

Market cap
38.42M
Market cap38.42M
Price-Earnings ratio
-5.96
Price-Earnings ratio-5.96
Dividend yield
Dividend yield
Average volume
236.36K
Average volume236.36K
High today
$0.975
High today$0.975
Low today
$0.9202
Low today$0.9202
Open price
$0.9504
Open price$0.9504
Volume
132.97K
Volume132.97K
52 Week high
$2.27
52 Week high$2.27
52 Week low
$0.7801
52 Week low$0.7801

Stock Snapshot

As of today, Rockwell Medical(RMTI) shares are valued at $0.96. The company's market cap stands at 38.42M, with a P/E ratio of -5.96.

As of 2026-01-14, Rockwell Medical(RMTI) stock has fluctuated between $0.92 and $0.98. The current price stands at $0.96, placing the stock +4.1% above today's low and -1.8% off the high.

The Rockwell Medical(RMTI)'s current trading volume is 132.97K, compared to an average daily volume of 236.36K.

During the past year, Rockwell Medical(RMTI) stock moved between $0.78 at its lowest and $2.27 at its peak.

During the past year, Rockwell Medical(RMTI) stock moved between $0.78 at its lowest and $2.27 at its peak.

People also own

Based on the portfolios of people who own RMTI. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .